|
|
EQSNews: Formycon AG
/ Key words: Agreement
MS Pharma becomes Partner for the Commercialization of FYB203, Formycon’s Biosimilar Candidate to Eylea® Aflibercept, in the MENA Region
15.05.2024 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
Presse... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Formycon AG
/ Key words: Quarterly / Interim Statement/Quarter Results
Formycon reports on successful operating business and financial figures for the first quarter of 2024
08.05.2024 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
Press Release // M... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Formycon AG
/ Key words: AGM/EGM/Personnel
Formycon invites to the Annual General Meeting on June 12, 2024 in Munich
07.05.2024 / 11:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Press release // 07 May 2024
Formycon invites to the Ann... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Formycon AG
/ Key words: Quarterly / Interim Statement/Conference
Formycon hosts conference call on the results of the first quarter 2024
02.05.2024 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
Press Release // May 02, 2024
Formyc... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Formycon AG
/ Key words: Annual Report/Forecast
Formycon reports audited annual results for the financial year 2023 – Looking back on a successful operative year and exceeded guidance
25.04.2024 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
P... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Formycon AG
/ Key words: Conference/Annual Results
Formycon invites to the conference call on the results of the financial year 2023 and announces participation in international investor conferences in the 2nd quarter of 2024
22.04.2024 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: Formycon AG
/ Key words: Preliminary Results/Forecast
Convincing overall performance Formycon reports preliminary results for the financial year 2023 and exceeds forecast
12.04.2024 / 22:15 CET/CEST
The issuer is solely responsible for the content of this announcement.
Press release // 1... Lire le communiqué |
|
| |
|
| |
